Author's posts
Doctors Successfully Transplanted A Gene-Edited Pig Kidney – And They Have Plans To Scale Up
The successful transplantation by scientists at University of Alabama-Birmingham into a brain-dead human body paves the way to clinical trials — and hope for thousands of patients suffering kidney disease.
Valo Health Is Partnering With Charles River Laboratories To Accelerate Preclinical Drug Discovery
The two companies will begin offering its combined platform product in mid-2022.
Valo Health Is Partnering With Charles River Laboratories To Accelerate Preclinical Drug Discovery
The two companies will begin offering their combined platform product in mid-2022.
Better Vaccines, New Treatments And More Tests: Healthcare Companies Reveal Covid Plans
Pfizer, Moderna, Regeneron and many other healthcare companies presented at the 40th annual J.P. Morgan Healthcare Conference and outlined their plans to continue fighting Covid this year.
Digital Health Startup Transcarent Just Raised $200 Million To Grow Its Concierge Medical Business
The company, helmed by former Livongo CEO Glen Tullman, just raised a series C round at a $1.6 billion valuation.
This Startup Raised Over $500 Million To Find Better Drugs With Nobel Prize-Winning Microscopes
Eikon Therapeutics uses high-resolution microscopes that view cell activity in real time, with an eye to using that data to accelerate drug discovery.
InnovationRx: Treating ‘Undruggable’ Diseases; Plus, Omicron In Europe
InnovationRx is your weekly digest of healthcare news. Sign up!
New Data Confirms Covid Antiviral Drug 89% Effective At Preventing Hospitalizations And Death, Pfizer Says
The pharmaceutical giant says new data from its Phase 2/3 studies a previous analysis of the drug’s effectiveness.
FDA Greenlights Booster Shots Of Pfizer/BioNTech’s Covid Vaccine For 16 And 17-Year-Olds
Pfizer and BioNTech will also apply to the FDA to expand the approval of their companies’ vaccine to include the third dose.
This Biotech Company Raised $40 Million To Develop Treatments For ‘Undruggable’ Diseases
Totus Medicines’ has come out of stealth with a technology that could enable it to treat cancers with known targets but no specific drugs—and it’s going into clinical trials next year.
